Health
Bangladesh reports first death from Nipah virus this year
Bangladesh on Monday reported its first death this year from the Nipah virus when a man died after drinking raw date juice. The virus was
Suspected counterfeit Ozempic linked to three hypoglycaemia cases in US
Last year in the US, three people sought medical attention for dangerously low blood sugar levels after taking allegedly counterfeit versions of Novo Nordisk’s diabetes
Gene therapy restores hearing in five out of six deaf children in trial
An experimental gene therapy being developed by a Chinese company restores hearing in children with congenital deafness, researchers working on a clinical trial reported Wednesday,
Lilly’s Mujaro dose will be available in limited quantities in the US until next month
Eli Lilly’s diabetes drug Munjaro will be available in limited quantities until February 2024 due to increased demand, according to the US Food and Drug
Walgreens will consider selling Shields Health for more than $4bn
Walgreens Boots Alliance is considering selling speciality pharmaceutical company Shields Health Solutions, Bloomberg News reported on Tuesday, citing people familiar with the situation. The report
Biden administration urges U.S. Supreme Court to strike down abortion pill ban
A 2023 court ruling that would restrict access to the abortion pill threatens to undermine the Food and Drug Administration’s authority and harm the U.S.
US FDA requires ‘boxed warning’ on CAR-T cancer therapies
A US health regulator on Monday asked a slew of drug makers, including Gilead Sciences, Johnson & Johnson and Novartis, to add a strong warning
US FDA requires ‘boxed warning’ on CAR-T cancer therapies
A U.S. health regulator said Monday that companies will be required to add a strong warning to prescribing information for cancer drugs known as CAR-T
France’s Sanofi to buy US drugmaker INBRX-101 for about $2.2bn
French healthcare company Sanofi has agreed to buy drug development project INBRX-101 from its parent company Inhibrx for about $2.2 billion in a bid to
The CDC reports that the JN.1 variant accounts for 86% of COVID cases in the US
The US Centers for Disease Control and Prevention on Monday estimated that COVID sub-variant JN.1 accounted for about 85.7% of cases in the US as